Bähr, O., Hattingen, E., Rieger, J., & Steinbach, J. P. (2011). Bevacizumab-induced tumor calcifications as a surrogate marker of outcome in patients with glioblastoma. Oxford University Press.
Chicago-tyylinen lähdeviittausBähr, Oliver, Elke Hattingen, Johannes Rieger, ja Joachim P. Steinbach. Bevacizumab-induced Tumor Calcifications As a Surrogate Marker of Outcome in Patients With Glioblastoma. Oxford University Press, 2011.
MLA-viiteBähr, Oliver, Elke Hattingen, Johannes Rieger, ja Joachim P. Steinbach. Bevacizumab-induced Tumor Calcifications As a Surrogate Marker of Outcome in Patients With Glioblastoma. Oxford University Press, 2011.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.